FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Sep 21, 2010
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on September 21, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- September 21, 2010
- Product Type
- Biologics
View Company Profile
ID · 4e4f56fd-5a4d-4a48-af70-48c8c9f0e95b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 680714
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 12, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 14, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1256154 - 2024-11-12
- FDA Inspection 1071897 - 2018-11-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.